Be The Match BioTherapies presents at the CAR-TCR Summit 2017 on Sept. 6
MINNEAPOLIS – Sept. 2017
Be The Match BioTherapies® is participating in the CAR-TCR Summit 2017 in Boston, Mass., Sept. 5-8, 2017.
On Sept. 6, Molly McCormick, MA, CHTC, will present “Keeping the patient central in personalized medicine: How patient case management is essential to cell therapy supply chain delivery.” Her presentation is part of the CAR-TCR Commercialization Stream.
McCormick is the vice president of Case Management and Operations Services at Be The Match BioTherapies’ parent company, the National Marrow Donor Program® (NMDP)/Be The Match®.
About Be The Match BioTherapies
We partner with organizations pursuing new life-saving treatments in cellular therapy. Built on the foundation established over the last 30 years by the NMDP/Be The Match, we have unparalleled experience in personalized case management with a single point of contact, cell sourcing and collection, cell supply chain, immunogenetics and bioinformatics, research, and regulatory compliance.
By leveraging our proven capabilities and established relationships, we can bring customizable solutions to organizations in every stage of cellular therapy development — from discovery through commercialization. Discover how Be The Match BioTherapies can assist your company at BeTheMatchBioTherapies.com.